PVR (CD155) and Nectin-2 (CD112) as ligands of the human DNAM-1 (CD226) activating receptor: involvement in tumor cell lysis

被引:115
|
作者
Pende, D
Bottino, C
Castriconi, R
Cantoni, C
Marcenaro, S
Rivera, P
Spaggiari, GM
Dondero, A
Carnemolla, B
Reymond, N
Mingari, MC
Lopez, M
Moretta, L
Moretta, A
机构
[1] Ist Nazl Ric Canc, I-16132 Genoa, Italy
[2] Ist Giannina Gaslini, I-16148 Genoa, Italy
[3] Univ Genoa, DIMES, I-16132 Genoa, Italy
[4] Univ Genoa, DOBIG, I-16132 Genoa, Italy
[5] Ctr Eccellenza Ric Biomed, I-16132 Genoa, Italy
[6] INSERM, U 119, Inst Biol Canc & Immunol, F-13009 Marseille, France
关键词
natural killer cells; tumors; activating receptors; cellular ligands;
D O I
10.1016/j.molimm.2004.07.028
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The capability of NK lymphocytes to kill tumor cells depends on different receptors/ligands interactions. In order to identify the cellular ligands recognized by "orphan" triggering receptors, mice were immunized with NK susceptible target cells. mAbs were selected that inhibited NK cytotoxicity and recognized two different molecules of 70 and 60-65 kDa. Tryptic digestion and mass spectra analysis of purified proteins identified these molecules as PVR and Nectin-2, respectively. PVR-Fc and Nectin-2-Fc chimeric molecules stained COS-7 cells expressing the DNAM-1 activating receptor and conversely, PVR and Nectin-2 CHO-K cell transfectants were stained by DNAM-1-Fc. Thus, both PVR and Nectin-2 represent specific ligands for DNAM-1. Importantly, the specific interaction between DNAM- I (in NK cells) and PVR or Nectin-2 (in target cells) enhanced the NK-mediated lysis of tumor cells that was downregulated by mAb-mediated masking of the receptor or its ligands. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:463 / 469
页数:7
相关论文
共 43 条
  • [21] The murine pan T cell marker CD96 is an adhesion receptor for CD155 and nectin-1
    Seth, S.
    Maier, M. K.
    Qiu, Q.
    Ravens, I.
    Kremmer, E.
    Foerster, R.
    Bernhardt, G.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2007, 364 (04) : 959 - 965
  • [22] MD Simulation Reveals Regulation of Mechanical Force and Extracellular Domain 2 on Binding of DNAM-1 to CD155
    Fang, Liping
    Zhao, Yang
    Guo, Pei
    Fang, Ying
    Wu, Jianhua
    MOLECULES, 2023, 28 (06):
  • [23] Natural killer cells genetically modified to overexpress DNAM-1 exert enhanced antitumor responses against CD112/CD155+sarcomas and other malignancies.
    Sayitoglu, Ece C.
    Chrobok, Michael
    Georgoudaki, Anna-Maria
    Josey, Benjamin J.
    Hartman, Michelle
    Vallabhaneni, Esha
    Herekar, Rajeev
    Bergeron, Savannah
    Krueger, Robin
    Sutlu, Tolga
    Alici, Evren
    Temple, Harry T.
    Duru, Adil D.
    CANCER IMMUNOLOGY RESEARCH, 2020, 8 (04) : 64 - 65
  • [24] Nitric oxide donors increase PVR/CD155 DNAM-1 ligand expression in multiple myeloma cells: role of DNA damage response activation
    Fionda, Cinzia
    Abruzzese, Maria Pia
    Zingoni, Alessandra
    Soriani, Alessandra
    Ricci, Biancamaria
    Molfetta, Rosa
    Paolini, Rossella
    Santoni, Angela
    Cippitelli, Marco
    BMC CANCER, 2015, 15
  • [25] Nitric oxide donors increase PVR/CD155 DNAM-1 ligand expression in multiple myeloma cells: role of DNA damage response activation
    Cinzia Fionda
    Maria Pia Abruzzese
    Alessandra Zingoni
    Alessandra Soriani
    Biancamaria Ricci
    Rosa Molfetta
    Rossella Paolini
    Angela Santoni
    Marco Cippitelli
    BMC Cancer, 15
  • [26] LK7 increased NK-cell mediated lysis of non-small cell lung cancer cells by down-regulating CD155 and CD112
    Ng, W.
    Yao, C.
    Wang, L.
    Gong, C.
    Zhu, X.
    Zhu, S.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1909 - 1909
  • [27] DNAM-1/CD155 Interactions Promote Cytokine and NK Cell-Mediated Suppression of Poorly Immunogenic Melanoma Metastases
    Chan, Christopher J.
    Andrews, Daniel M.
    McLaughlin, Nicole M.
    Yagita, Hideo
    Gilfillan, Susan
    Colonna, Marco
    Smyth, Mark J.
    JOURNAL OF IMMUNOLOGY, 2010, 184 (02): : 902 - 911
  • [28] Increased Soluble CD226 in Sera of Patients with Cutaneous T-Cell Lymphoma Mediates Cytotoxic Activity against Tumor Cells via CD155
    Takahashi, Naomi
    Sugaya, Makoto
    Suga, Hiraku
    Oka, Tomonori
    Kawaguchi, Makiko
    Miyagaki, Tomomitsu
    Fujita, Hideki
    Inozume, Takashi
    Sato, Shinichi
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2017, 137 (08) : 1766 - 1773
  • [29] CD226 (DNAM-1) is involved in lymphocyte function-associated antigen 1 costimulatory signal for naive T cell differentiation and proliferation
    Shibuya, K
    Shirakawa, J
    Kameyama, T
    Honda, S
    Tahara-Hanaoka, S
    Miyamoto, A
    Onodera, M
    Sumida, T
    Nakauchi, H
    Miyoshi, H
    Shibuya, A
    JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (12): : 1829 - 1839
  • [30] Immune checkpoint molecule DNAM-1/CD112 axis is a novel target for natural killer-cell therapy in acute myeloid leukemia
    Kaito, Yuta
    Sugimoto, Emi
    Nakamura, Fumi
    Tsukune, Yutaka
    Sasaki, Makoto
    Yui, Shunsuke
    Yamaguchi, Hiroki
    Goyama, Susumu
    Nannya, Yasuhito
    Mitani, Kinuko
    Tamura, Hideto
    Imai, Yoichi
    HAEMATOLOGICA, 2024, 109 (04) : 1107 - 1120